Chevignard Mathilde, Câmara-Costa Hugo, Doz François, Dellatolas Georges
Rehabilitation Department for children with acquired neurological injury, Saint Maurice Hospitals, Saint Maurice, France (M.C.); Sorbonne Universités, UPMC University Paris 06, CNRS UMR 7371, INSERM UMR S 1146, Laboratoire d'Imagerie Biomédicale (LIB), F-75005, Paris, France (M.C.); Groupe de Recherche Clinique Handicap Cognitif et Réadaptation; UPMC Paris 6, Paris, France (M.C.); Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France.(H.C.-C, G.D.); Institut Curie and University Paris Descartes, Sorbonne Paris Cité, France (F.D.).
Neurooncol Pract. 2017 Jun;4(2):82-97. doi: 10.1093/nop/npw013. Epub 2016 Aug 26.
Medulloblastoma is the most common malignant central nervous system tumor in children. Treatment most often includes surgical resection, craniospinal irradiation, and adjuvant chemotherapy. Although survival has improved dramatically, the tumor and its treatments have devastating long-term side effects that negatively impact quality of survival (QoS). The objective was to review the literature on QoS following childhood medulloblastoma.
This narrative review is based on a Medline database search and examination of the reference lists of papers selected.
Frequent problems after medulloblastoma treatment include medical complications, such as long-term neurological and sensory (hearing loss) impairments; endocrine deficits, including growth problems; and secondary tumors. Neurocognitive impairment is repeatedly reported, with decreasing cognitive performances over time. Although all cognitive domains may be affected, low processing speed, attention difficulties, and working memory difficulties are described as the core cognitive deficits resulting from both cerebellar damage and the negative effect of radiation on white matter development. Long-term psychosocial limitations include low academic achievement, unemployment, and poor community integration with social isolation. Important negative prognostic factors include young age at diagnosis, conventional craniospinal radiotherapy, presence of postoperative cerebellar mutism, and perioperative complications. The influence of environmental factors, such as family background and interventions, remains understudied.
Future studies should focus on the respective impact of radiation, cerebellar damage, genomic and molecular subgroup parameters, and environmental factors on cognitive and psychosocial outcomes. Long-term (probably lifelong) follow-up into adulthood is required in order to monitor development and implement timely, suitable, multi-disciplinary rehabilitation interventions and special education or support when necessary.
髓母细胞瘤是儿童最常见的恶性中枢神经系统肿瘤。治疗通常包括手术切除、全脑全脊髓放疗和辅助化疗。尽管生存率有了显著提高,但肿瘤及其治疗方法会产生严重的长期副作用,对生存质量(QoS)产生负面影响。目的是综述关于儿童髓母细胞瘤后生存质量的文献。
本叙述性综述基于对Medline数据库的检索以及对所选论文参考文献列表的审查。
髓母细胞瘤治疗后的常见问题包括医学并发症,如长期神经和感觉(听力丧失)障碍;内分泌缺陷,包括生长问题;以及继发性肿瘤。神经认知障碍屡有报道,且随着时间推移认知能力不断下降。尽管所有认知领域都可能受到影响,但处理速度慢、注意力困难和工作记忆困难被描述为小脑损伤以及辐射对白质发育的负面影响所导致的核心认知缺陷。长期的社会心理限制包括学业成绩低、失业以及社区融入差和社会隔离。重要的负面预后因素包括诊断时年龄小、传统全脑全脊髓放疗、术后小脑缄默症的存在以及围手术期并发症。环境因素的影响,如家庭背景和干预措施,仍研究不足。
未来的研究应关注辐射、小脑损伤、基因组和分子亚组参数以及环境因素对认知和社会心理结果的各自影响。需要对成年期进行长期(可能是终身)随访,以监测发育情况,并在必要时及时实施适当的多学科康复干预以及特殊教育或支持。